Trial ID or NCT#

NCT01912534

Status

RECRUITING

Purpose

The purpose of this trial is to determine whether treatment with valsartan will have beneficial effect in early hypertrophic cardiomyopathy (HCM) by assessing many domains that reflect myocardial structure, function and biochemistry.

Official Title

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

Eligibility Criteria

Ages Eligible for Study: 8 Years to 45 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Euan A. Ashley
Cardiologist
Professor of Medicine (Cardiovascular) and, by courtesy, of Pathology at the Stanford University Medical Center
Matthew Wheeler
Cardiologist
Clinical Assistant Professor, Medicine - Cardiovascular Medicine

Contact us to find out if this trial is right for you.

CONTACT

Euan Ashley, MD, PhD
(650) 498-4900